{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Is the UK set to become a radiopharma leader?","description":"The latest episode of the DDW \u2018In Conversation With\u2019 series is available to listen to now. This week, Bruno Quinney speaks to Dr Juliana Maynard, Head of Translational Imaging at Medicines Discovery Catapult. MDC recently announced a partnership with the UK National Nuclear Lab, and Maynard's work is at the forefront of advances being made in radiopharmaceuticals. Bruno speaks to Juliana about investment in the radiopharmaceuticals industry, why radiopharmaceuticals are an exciting approach in the cancer treatment space, and what it would mean for patients if the UK becomes a radiopharma leader. You can listen below, or find The Drug Discovery World Podcast on&amp;nbsp;Spotify,&amp;nbsp;Google Play&amp;nbsp;and&amp;nbsp;Apple Podcasts. ","author_name":"The Drug Discovery World Podcast","author_url":"https:\/\/www.ddw-online.com\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41375360\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/202183220"}